Role of fecal calprotectin as a biomarker of intestinal inflammation in ulcerative colitis: a prospective study

Abstract

Background: The clinical utility of non-invasive markers in the diagnosis and monitoring of ulcerative colitis (UC) has been intensively studied. The aim of our study was to evaluate the value of fecal calprotectin (FC) in differentiating between UC and irritable bowel syndrome (IBS), and in estimating inflammatory activity in UC.

Keywords

• fecal calprotectin
• ulcerative colitis
• irritable bowel syndrome